Brainstorm Cell Therapeutics | BCLI - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Biogen USD 1.96B 69.6M 2026-03
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Cipla INR 59.27B 1.71B 2026-03
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Cytokinetics USD 200.58M 4.46M 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
Grifols EUR 1.99B 217.4M 2025-12
Halozyme Therapeutics USD 192.19M 18.88M 2026-03
Mesoblast USD 82.31M 26.16M 2025-12